Skip to content
SEC Form 4insider transactionsfree

GILEAD SCIENCES, INC. insider buying and selling

19 Form 4 filings against GILEAD SCIENCES, INC. (GILD) in the last 90 days. Below are the transactions from 4 recent filings, one per insider where the window allows, as filed.

Window 2026-08-23 to 2026-11-21CIK 0000882095newest filing 2026-11-17source: SEC EDGAR, Form 4 XML
DateInsider and roleTransactionCodeSharesPriceOwned after
2026-11-16Mercier JohannaChief Comm & Corp Aff Officeroption exerciseM25,000$72.34138,684
2026-11-16Mercier JohannaChief Comm & Corp Aff Officeropen-market saleS13,922$169.97124,762
2026-11-16Mercier JohannaChief Comm & Corp Aff Officeropen-market saleS13,178$171.09111,584
2026-11-16Mercier JohannaChief Comm & Corp Aff Officeropen-market saleS900$171.69110,684
2026-11-16Dickinson Andrew DChief Financial Officeropen-market saleS3,000$171.47158,096
2026-11-12Kramer Kelly A.directoroption exerciseM10,376$66.9211,715
2026-11-12Kramer Kelly A.directoropen-market saleS1,676$168.2310,039
2026-11-12Kramer Kelly A.directoropen-market saleS3,800$169.446,239
2026-11-12Kramer Kelly A.directoropen-market saleS4,700$170.491,539
2026-11-12Kramer Kelly A.directoropen-market saleS200$171.441,339
2026-11-06Cain Wettan Keeley MEVP Gen Counsel, Legal & Compopen-market saleS3,399$164.115,360

What the filings show

Across the 4 filings read here, 4 insiders at GILEAD SCIENCES, INC. (GILD) filed; between them they reported 9 open-market sales of 44,775 shares worth about $7.6M.

The largest by value was Mercier Johanna (Chief Comm & Corp Aff Officer), with about $4.8M sold on the open market.

19 Form 4 filings were made against GILEAD SCIENCES, INC. in the 90 days to November 21, 2026; the paid report reads all of them.

Transaction codes: P is an open-market purchase, S an open-market sale, A a grant or award, M an option exercise, F shares surrendered for tax. 0 open-market buys and 9 open-market sales in the rows above.
free alert

Free. One email a day at most, only when something changes. Confirm by email first; unsubscribe with one click. Privacy.

The Form 4 flow against GILEAD SCIENCES, INC., parsed and explained

The free view above is the newest few filings. The paid report reads the newest Form 4 filings of the last 90 days (up to 100), separates open-market buys and sales from awards, exercises and tax withholding, totals the flow per insider, flags 10b5-1 plans where the filing notes them, and hands you a cited write-up plus a downloadable transactions table.

agents: POST /v1/insider-report with {"ticker":"GILD"} over x402 or MPP, $0.60

Sample output and API docsall reports

Generated from public SEC EDGAR filings. Filing data is shown as filed. This is information, not investment advice.